AzurRx BioPharma Inc (AZRX)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current AZRX market cap is 46.58M. The company's latest EPS is USD -1.1928 and P/E is -2.48.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.42M | -4.09M | -9.23M | -3.3M | -1.89M |
| Net Income | -3.48M | -4.18M | 5.5M | -8.85M | -2.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 8.09M | 0 |
| Operating Income | -14.74M | -26.43M | -59.06M | -12.68M | -15.77M |
| Net Income | -15.18M | -32.67M | -58.54M | -14.97M | -16.1M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 5.93M | 6.88M | 91.13M | 86.29M | 85.82M |
| Total Liabilities | 2.65M | 3.28M | 13.27M | 15.49M | 15.77M |
| Total Equity | 3.28M | 3.6M | 16.18M | 9.12M | 8.37M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 8.9M | 12.92M | 11.79M | 5.44M | 6.88M |
| Total Liabilities | 4.29M | 15.57M | 19.61M | 2.7M | 3.28M |
| Total Equity | 4.62M | -2.64M | -7.82M | 2.74M | 3.6M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -8.94M | -12.38M | -3.75M | -7.2M | -9.05M |
| Investing | N/A | -500k | 88k | 88k | 88k |
| Financing | 10.87M | 15.23M | 3.38M | 4.06M | 5.61M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -14.03M | -11.22M | -32.29M | -22.34M | -12.38M |
| Investing | -24k | 88k | -10.32M | N/A | -500k |
| Financing | 13.15M | 17.05M | 44.76M | 15.74M | 15.23M |
| Market Cap | 46.58M |
| Price to Earnings Ratio | -2.48 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 10.76 |
| Price to Book Ratio | 11.09 |
| Dividend Yield | - |
| Shares Outstanding | 13.5M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.1 (2.85%) |
| Company Name | AzurRx BioPharma Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.enterothera.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
